Brief Biography:
Name: Nermin Salah Ahmed Mostafa
Title: Dr
Professional Achievements
Publications Nermin S. Ahmed, Bernard D. Gary, Heather N. Tinsley, Gary A. Piazza, Stefan Laufer, and Ashraf H. Abadi. Design, Synthesis and Structure-Activity Relationship of Functionalized Tetrahydro-β-carboline Derivatives as Novel PDE5 Inhibitors. Arch. Pharm.,2011, ;344(3),149-57.
Nermin S. Ahmed,Bernard D. Gary,Gary A. Piazza, Stefan Laufer, and Ashraf H. Abadi. A Novel Access to Arylated and Heteroarylated Beta-Carboline Based PDE5 Inhibitors. Med. Chem., 2010,6, 374-387 .
Ashraf H. Abadi, Dalal A. Abouel-Ella, Nermin S. Ahmed, Bernard D. Gary, Jose T. Thaiparambil,
Heather N. Tinsley, AdamB. Keeton, Gary A. Piazza. Synthesis of Novel Tadalafil Analogues
and their Evaluation as Phosphodiesterase Inhibitors and Anticancer Agents. Arzneimittelforschung, 2009, 59 (8), 415–421.
Postdoctoral projects
German Egyptian Research Short Term Scholarships (GERSS)
Title of the project: Design and stereospecific synthesis of novel tetrahydro-ß- carbolines as kinesin Eg5 inhibitors.
Status: accepted ID number: 17549
L’Oreal-UNESCO Pan Arab Regional Fellowships for Women in Science 2011
Title of the project: Design, Synthesis and Biological evaluation of selective estrogen receptor modulators (SERM) with anti-proliferative effect on human breast cancer cells
Status: under review.
Research Grants Program for young Egyptian postdoctoral researchers Bibliotheca Alexandrina
Title of the project: Design, Synthesis and Biological evaluation of selective estrogen receptor modulators (SERM) with anti-proliferative effect on human breast cancer cells
Status: under review ID number: 47
The COMSTECH-TWAS Joint Research Grants Program
Title of the project: Design and stereospecific synthesis of novel tetrahydro-ß- carbolines as kinesin Eg5 inhibitors.
Status: Under review
Academic positions:
Lecturer , pharmaceutical chemistry , Faculty of Pharmacy and Biotechnology
Research interests:
Synthetic medicinal organic chemistry in the areas of antitumors and enzyme inhibitors.
Computer-Aided Drug Design.
What I think of the idea behind WebmedCentral:
A High caliber web portal that will help young sciencetific authors to access and publish a huge number of eminent articles.
All site content, except where otherwise noted, is licensed under a
Creative Commons Attribution License